The National Institute of Allergy and Infectious Diseases (NIAD) is
seeking volunteers for a study of an experimental AIDS vaccine. At the
recent AIDS conference in Stockholm, NIAD deputy clinical director H.
Clifford Lane reported that 20 of 60 volunteers have developed an immune
response in the study. MicroGensys, a Connecticut firm, manufactured the
vaccine from a protein derived from HIV's genetic material. Some
volunteers developed flu-like symptoms and fevers lasting up to 24 hours,
but there have been no serious side-effects. Volunteers must be gay or
bisexual men and must go to Bethesda, Md., once a week for the first
month after vaccination and monthly for a year thereafter.